Highlights Biotechnology Assets, S.A.

Equities

BST

ES0184980003

Market Closed - BME Other stock markets 11:35:20 2024-07-03 am EDT			5-day change	1st Jan Change
0.333 ^EUR	0.00%		+0.91%	-15.91%

Apr. 05	Biotechnology Assets, S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Biotechnology Assets, S.A. Auditor Raises 'Going Concern' Doubt	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Biotechnology Assets, S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 04	CI
Biotechnology Assets, S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-10	CI
Biotechnology Assets, S.A. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-12	CI
ADL Bionatur Solutions, S.A. Reports Earnings Results for the Half Year Ended June 30, 2021	21-10-29	CI
Adl Bionatur Solutions, S.A. Reports Earnings Results for the Full Year Ended December 31, 2020	21-05-11	CI
Kartesia Advisor LLP acquired 51% stake in ADL Biopharma from ADL Bionatur Solutions, S.A. and Black Toro Capital LLP.	20-10-06	CI
ADL Bionatur Solutions Wins New Fermentation Client With Contract Revenues of EUR 20 Million	19-12-02	CI
ADL Bionatur Solutions Announces Earnings Results for the First Six Months of 2019; Provides Guidance for the Full Year 2019	19-10-10	CI
ADL Bionatur Solutions, S.A. Provides Sales Guidance for 2019	19-08-07	CI
ADL Bionatur Solutions Enters into an Initial EUR 13 Million Strategic Alliance with Japanese Pharma Company	19-08-07	CI
ADL Bionatur Solutions and Amyris, Inc. Expand Contract to 2020	19-07-22	CI
ADL Bionatur Solutions Increases 2019 Production for Global Nutrition Company for Additional Revenues of over EUR 2.5 Million	19-07-09	CI
ADL Bionatur Solutions, S.A. Provides Sales Guidance for 2019	19-05-06	CI
Nutricion Center NC and ADL Bionatur Solutions Sign Strategic Alliance to Tackle Weight Control by Rebalancing the Gut Microbiome	19-02-19	CI
Amyris and ADL Bionatur Solutions Expand Production Agreement to Meet Growing Demand	18-12-10	CI
Fermentalg and ADL BioPharma Announces Major Manufacturing Alliance to Produce Omega 3 Food Supplements	18-09-26	CI
Amyris Expands Production Contract with ADL BioPharma Due to Demand Growth	18-06-27	CI
ADL BioPharma completed the acquisition of Bioorganic Research and Services S.A. in a reverse merger transaction.	18-04-26	CI
ADL BioPharma signed a binding agreement to acquire Bioorganic Research and Services S.A. in a reverse merger transaction.	17-11-29	CI
Wacker Biosolutions completed the acquisition of Fermentation Plant in Spain from Antibióticos SLU.	16-12-30	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Biotechnology Assets, S.A.

Equities

BST

ES0184980003

Highlights

Filters